Calcipotriol or clobetasol propionate occluded with a hydrocolloid dressing for treatment of nummular psoriasis
Nielsen, P.G.
Acta Dermato-Venereologica 73(5): 394
1993
ISSN/ISBN: 0001-5555 PMID: 7904413 Document Number: 407199
Document emailed within 1 workday
Related Documents
Berardesca, E.; Vignoli, G.P.; Farinelli, N.; Vignini, M.; Distante, F.; Rabbiosi, G. 1994: Non-invasive evaluation of topical calcipotriol versus clobetasol in the treatment of psoriasis Acta Dermato-Venereologica 74(4): 302-304Breneman, D.; Fleischer, A.B.; Kaplan, D.; Lebwohl, M.; Miller, B.; Pariser, D.; Rist, T.; Swinyer, L.; Liu, Y.; Foley, V. 2005: Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream Journal of Drugs in Dermatology: Jdd 4(3): 330-336
Hradil, E.; Lindström, C.; Möller, H. 1978: Intermittent treatment of psoriasis with clobetasol propionate Acta Dermato-Venereologica 58(4): 375-377
Lahfa, M.; Mrowietz, U.; Koenig, M.; Simon, J.C. 2003: Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis European Journal of Dermatology: Ejd 13(3): 261-265
Jarratt, M.T.; Clark, S.D.; Savin, R.C.; Swinyer, L.J.; Safley, C.F.; Brodell, R.T.; Yu, K. 2006: Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis Cutis 78(5): 348-354
Feldman, S.R.; Winkelman, W.; Baum, E.; Preston, N. 2013: Predicting improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray Journal of Drugs in Dermatology: Jdd 12(12): 1456-1460
Beutner, K.; Chakrabarty, A.; Lemke, S.; Yu, K. 2006: An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis Journal of Drugs in Dermatology: Jdd 5(4): 357-360
Menter, A.; Abramovits, W.; Colón, L.E.; Johnson, L.A.; Gottschalk, R.W. 2009: Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis Journal of Drugs in Dermatology: Jdd 8(1): 52-57
Warino, L.; Balkrishnan, R.; Feldman, S.R. 2006: Clobetasol propionate for psoriasis: are ointments really more potent? Journal of Drugs in Dermatology: Jdd 5(6): 527-532
Hudson, C.P.; Kempers, S.; Menter, A.; Papp, K.; Smith, S.; Sofen, H.; Colón, L.E.; Johnson, L.A.; Gottschalk, R. 2011: An open-label, multicenter study of the efficacy and safety of a weekday/weekend treatment regimen with calcitriol ointment 3 microg/g and clobetasol propionate spray 0.05% in the management of plaque psoriasis Cutis 88(4): 201-207
Jarratt, M.; Breneman, D.; Gottlieb, A.B.; Poulin, Y.; Liu, Y.; Foley, V. 2004: Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis Journal of Drugs in Dermatology: Jdd 3(4): 367-373
Menter, M.A.; Caveney, S.W.; Gottschalk, R.W. 2012: Impact of clobetasol propionate 0.05% spray on health-related quality of life in patients with plaque psoriasis Journal of Drugs in Dermatology: Jdd 11(11): 1348-1354
Jacobson, C.; Cornell, R.C.; Savin, R.C. 1986: A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis Cutis 37(3): 213-4 216 218-20
Sofen, H.; Hudson, C.P.; Cook-Bolden, F.E.; Preston, N.; Colón, L.E.; Colón, L.E.; Caveney, S.W.; Gottschalk, R.W. 2011: Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial Journal of Drugs in Dermatology: Jdd 10(8): 885-892
Aparicio Gallego, E.; Castilla Peris, C.; Díez García, M.ía.T.; Dorado, A.; Mendoza, G.; Núñez Fernández, J.é M.ía.; Pascual Ríos, J.ús. 2005: Therapeutic behavior of a hydrocolloid dressing. its evolution in the treatment of acute and chronic dermal ulcers Revista de Enfermeria 28(12): 49-55
Camacho, F.; Mazuecos, J.é 2002: Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight--a new study for the treatment of vitiligo Journal of Drugs in Dermatology: Jdd 1(2): 127-131
Lane, P.R.; Moreland, A.A.; Hogan, D.J. 1990: Treatment of actinic prurigo with intermittent short-course topical 0.05% clobetasol 17-propionate. A preliminary report Archives of Dermatology 126(9): 1211-1213
Duweb, G.A.; Eldebani, S.; Alhaddar, J. 2003: Calcipotriol cream in the treatment of flexural psoriasis International Journal of Tissue Reactions 25(4): 127-130
Kircik, L.H.; Tropmann, C. 2011: Treatment of mild-to-moderate chronic hand dermatitis with clobetasol propionate 0.05% EF foam: results from an open-label study Journal of Drugs in Dermatology: Jdd 10(12): 1398-1402
Toole, J.W.P. 2007: Calcipotriol and betamethasone dipropionate for the treatment of psoriasis: a 52-week study Skin Therapy Letter 12(4): 1-3